Viracta Therapeutics Market Cap

Viracta Therapeutics has a market cap or net worth of $32.83 million as of April 25, 2024. Its market cap has decreased by -33.81% in one year.

Market Cap

32.83M

Enterprise Value

5.80M

1-Year Change

-33.81%

Ranking

#4786

Market Cap Chart

Since September 27, 2005, Viracta Therapeutics's market cap has decreased from $139.50M to $32.83M, a decrease of -76.46%. That is a compound annual growth rate of -7.49%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	32.80M	-1.50%
Apr 23, 2024	33.30M	-3.76%
Apr 22, 2024	34.60M	2.67%
Apr 19, 2024	33.70M	-5.60%
Apr 18, 2024	35.70M	-2.99%
Apr 17, 2024	36.80M	30.96%
Apr 16, 2024	28.10M	-8.17%
Apr 15, 2024	30.60M	-32.30%
Apr 12, 2024	45.20M	-1.53%
Apr 11, 2024	45.90M	2.46%
Apr 10, 2024	44.80M	7.69%
Apr 9, 2024	41.60M	-0.95%
Apr 8, 2024	42.00M	4.74%
Apr 5, 2024	40.10M	-1.72%
Apr 4, 2024	40.80M	-4.67%
Apr 3, 2024	42.80M	-
Apr 2, 2024	42.80M	-1.83%
Apr 1, 2024	43.60M	8.73%
Mar 28, 2024	40.10M	-5.42%
Mar 27, 2024	42.40M	-
Mar 26, 2024	42.40M	1.92%
Mar 25, 2024	41.60M	9.19%
Mar 22, 2024	38.10M	-9.29%
Mar 21, 2024	42.00M	-5.41%
Mar 20, 2024	44.40M	11.84%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
electroCore	33.97M
CASI Pharmaceuticals	33.64M
Precision Optics Corporation	33.62M
MAIA Biotechnology	33.52M
Evogene	33.37M
Nutex Health	33.13M
VYNE Therapeutics	32.71M
Inspira Technologies Oxy B.H.N.	32.17M

Market Cap Rankings